How artificial intelligence is changing health technology assessment: evidence synthesis, economic modelling and the challenges of assessing AI.

The new Dutch guideline for economic evaluations in healthcare and what taking the societal perspective to the next level means.

Survival analysis 101: an easy start guide to analysing time-to-event data, including Kaplan-Meier curves and Cox regression.

How costs of illness should be handled in cost-effectiveness analysis: a review of the methodological debate.

Practical tools from EUnetHTA for health technology assessment in Europe, including the HTA Core Model.

A review of discrete choice experiments in health economics: design trends, applications and methodological issues.

Methodology and reporting characteristics of interrupted time series studies in healthcare, and how to do them well.

Health economic evaluation explained: cost-effectiveness, cost-utility and cost-benefit analysis principles.

Four decades of health economics: a 40-year bibliometric review of the field’s growth and themes.

Evaluating the economic value of genomic technologies: challenges and methods for health economists.

Overcoming challenges in the value assessment of innovative therapies such as gene and cell therapies.

How machine learning can enhance health policy literature reviews, from Cavallaro et al.